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ABSTRACT 
Background: Chemotherapy is the use of drugs to kill cancer cells. Because cancer cells generally grow and divide faster than 
normal cells, they are more susceptible to the action of these drugs. However, damage to healthy cells is unavoidable, and this 
damage accounts for the side effects linked to these drugs.  
Methodology: A cross section study was conducted at oncology department in Bugando Medical Centre. A sample of 216 people 
was recruited into the study. The data was collected by using the pre-constructed questionnaire. After data collection, the data was 
transferred into SPSS version 20 and analyzed. 
Results: The study found that 88 (40.7%) of the respondents were aware of the chemotherapy side effects whereby majority, 68 
(77.3%) of these had been informed by the doctor. Most of the respondents, 197 (92.1%) had a positive attitude towards the use of 
chemotherapy. 
Conclusion: There is still poor awareness of the chemotherapy side effects among the cancer patients attending and receiving 
chemotherapy in oncology department at Bugando Medical Centre. However, most of the respondents had positive attitude towards 
the use of chemotherapy 
Keywords: Awareness, attitude, chemotherapy, side effects and Tanzania. 
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INTRODUCTION 
Cancer, also known as a malignant tumor or malignant 
neoplasm is a group of diseases involving abnormal cell 
growth with the potential to invade or spread to other 
parts of the body
1
. 
Cancers as a group of diseases account for 
approximately 13% of all deaths each year worldwide, 
with the most common being: lung cancer (1.4 million 
deaths), stomach cancer (740,000 deaths), liver cancer 
(700,000 deaths), colorectal cancer (610,000 deaths), 
and breast cancer (460,000 deaths) 
2
. This makes 
invasive cancer the leading cause of death in the 
developed world and the second leading cause of death 
in the developing world.
3
 
Africa had 715,000 new cases of cancer in 2008 and 
542,000 deaths from cancer. This number is projected to 
1.28M new cases and 970,000 deaths by 2030 which is 
nearly double of the current situation 
4
. 
In Tanzania, there were only two cancer treatment 
centers in 2002 to serve the entire population of 46 
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million people. These two clinics have capacity to serve 
only about 5,000 of the estimated 30,000 new cancer 
cases each year. For many of the patients who manage 
to receive treatment, their cancers have already 
metastasized to the point that administering palliative 
care becomes the only remaining option
5
. 
Use of chemotherapy drugs is the cornerstone modality 
of the management of various types of cancers. These 
powerful medications circulate in the bloodstream and 
directly damage the cells that are actively growing. 
Because cancer cells generally grow and divide faster 
than normal cells, they are more susceptible to the 
action of these drugs.  However, damage to healthy cells 
is unavoidable, and this damage accounts for the side 
effects linked to these drugs 
6
. 
Chemotherapy drugs are also used as an adjuvant 
treatment (treatment given after surgery or radiation 
therapy) to kill any cancer cells that remains. It may also 
be used as neo-adjuvant therapy (treatment given before 
surgery or radiation therapy to shrink tumors). For 
cancers of the blood or lymph system, such as leukemia 
and lymphoma, chemotherapy may be the only 
treatment given. In addition, chemotherapy is used to 
treat recurrent cancer (cancer that comes back after 
treatment) or metastatic cancer (cancer that has spread to 
other parts of the body) 
7
 
The goals of treatment with chemotherapy drugs depend 
on the type of cancer and how much it has spread. In 
some situations, the primary goal of chemotherapy is to 
eliminate cancer cells and prevent recurrence. If it is not 
possible to eliminate the cancer cells, chemotherapy 
may be used to control the cancer by slowing its growth 
and/or to reduce symptoms caused by the cancer
6,8
. 
The side effects associated with chemotherapy are so 
noxious that result into poor adherence, poor quality of 
life, morbidity or even mortality 
9
. Early education and 
information to the patients on these side effects helps to 
manage and cope with them and improve the quality of 
life 
10
.  
METHODS 
Study Area 
This study was conducted at the oncology clinic in the 
oncology department at Bugando Medical Center. This 
is the largest referral hospital in the Lake zone of north 
western Tanzania that serves all cancer cases including 
those referred from other hospitals. Furthermore, this 
hospital is a care to 8 regions harboring around 14 
million citizens of Tanzania.  All outpatients and 
inpatient cancer patients are seen at the oncology clinic; 
therefore this was the most feasible study site to access 
the targeted study population. 
 Study Design 
A cross sectional design was employed. This involved 
primary data collection through interviewing the 
consented participants. 
 
 
Study population 
The study involved adult individuals aged 18 years or 
above who attend and receive chemotherapy treatment 
in oncology unit at Bugando Medical Centre. 
The sample size determination 
The estimated prevalence rate of cancer patients 
receiving chemotherapy at Bugando Medical Centre is 
83% according to the hospital oncology department 
cancer registry 
11
.  Therefore, the prevalence of 83 % 
was used in the estimation of the sample size using 
Fischer’s formula: 
n= Z
2 
x P (1-P)/d
2
 
     Where   n= sample size 
P = estimated prevalence rate of adherence to 
chemotherapy treatment=83% 
Z= 1.96 which is Z-value corresponding to a 
significance level of 0.05 
d= 0.05 which is the desired degree of accuracy for the 
study. 
Hence, n= 1.96
2 
x 0.83x (1-0.83)/ 0.05
2 
= 216 
Sample size = 216 people. 
Sampling method and recruitment of 
participants 
The participant was first recruited using eligibility 
assessment form through systematic random sampling 
method whereby every 2
nd
 patient leaving the 
consultation room at the oncology clinic, who met the 
inclusion criteria and signed an informed consent, was 
enrolled into the study.  
Data collection tools 
Pre-constructed semi-structured questionnaire was used 
to collect information from participants on the issues of 
knowledge and altitude towards chemotherapy side 
effects.  
Ethical Consideration 
The study started upon approval from the CUHAS/BMC 
Ethics and Research Committee and permission from 
BMC Oncology department. Written informed consent 
was sought from all participants first before 
administering the study tools. All participants were 
required to fully understand the study, know their rights 
and voluntarily sign the informed consent before 
participation. Participants were free to ask any questions 
regarding the study, their rights and seek any 
clarification. All information was kept confidential. 
Data Management 
Raw data was collected using study tools and entered 
into a password protected Microsoft excel (version 
2007) Database and then exported to SPSS version 20 
for analysis. Before and after analysis, the filled 
questionnaires were stored in a lockable cabinet by a 
researcher. They then got moved to a lockable cabinet in 
the statistician’s office during data entry and analysis. 
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Upon completion of Data entry, hard copy forms were 
compared with the entered data to identify errors and 
corrections made appropriately. 
RESULTS 
The study recruited 216 people, the number which was 
equivalent to the pre-estimated sample size. These were 
the individuals at the age of 18 years or above who had 
started the chemotherapy and consented to be part of the 
study.  
Social demographic characteristics of 
participants 
The study included the people of different social 
demographic characteristics as shown in the table 1 
below.
  
Table 1: Social- demographic characteristics 
Variable  Frequency Percentages (%) 
Age 
      18- 30 
      31- 40 
      41- 50  
      51- 60 
       60+ 
Sex  
       Male  
       Female 
Marital status 
         Single  
         Married 
         Divorced 
         Widowed 
Occupation  
         Peasants 
         Business 
         Employed 
         Self-employment 
        Unemployed 
Educational level. 
            Primary education 
            Secondary education 
            College/university 
            No education. 
Religion 
         Christian 
          Muslim 
          Pagans 
Residence 
         Rural 
         Urban. 
 
28 
38 
60 
56 
34 
 
102 
114 
 
31 
143 
9 
33 
 
113 
13 
24 
13 
53 
 
151 
46 
6 
13 
 
136 
68 
12 
 
161 
55 
 
13 
17.6 
27.8 
25.9 
15.7 
 
47.2 
52.8 
 
14.4 
66.2 
41.7 
15.3 
 
52.3 
6 
11.1 
6 
24.5 
 
69.9 
21.3 
27.7 
6 
 
63 
31.5 
55.6 
 
74.5 
25.5 
 
Finding of the study 
Awareness of chemotherapy side effects 
To assess the awareness on chemotherapy side effects, 
the participants were interviewed if they had received 
any information regarding the side effects before the 
start of chemotherapy and it was found that 88 
participants (40.7%) were informed of chemotherapy 
and therefore aware of them while 128 people (59.3%) 
denied to have been given any information before the 
commencement of chemotherapy. 
 
Table 2: Pre-information on chemotherapy side effects 
 Participant’s Response Frequency Percent 
 Aware 88 40.7 
Not aware  128 59.3 
Total 216 100.0 
 
Furthermore, among those who said were informed of 
the side effects, it was found from that, majority of them 
were informed about occurrence of vomiting 85 (96.6%) 
and alopecia 82 (93.2%) table 3. 
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Table 3: Side effects informed about 
Side effect Frequency  Percentage  
Vomiting 
Nausea 
Alopecia 
Diarrhoea 
Fatigue 
Pain 
Bleeding 
Anaemia 
Immune-suppression 
Loss of apatite 
Infertility.   
 
85 
62 
82 
25 
62 
28 
4 
12 
2 
7 
0 
 
96.6 
70.5 
93.2 
28.4 
70.5 
31.8 
4.5 
13.6 
2.3 
8 
0 
 
Because cancer patients interact with various caregivers, 
the study went further to identify the informer of the side 
effects and it was found that, 68  (77.3%) were informed 
by the doctor, 19 (21.6%) were informed by the nurse 
and 1 (1.2%) respondent said was informed by a friend. 
The study also revealed that, none of participants among 
the informed participants was informed by the 
pharmacist (Table 4) 
 
Table 4: The informer of side effects 
 
 
The respondents were also interviewed on whether or 
not they experienced any side effects after the start of 
chemotherapy and 191 respondents (88.4%) said they 
experienced side effects following the commencement 
of chemotherapy whereby 25 respondents (11.6%) said 
had not experienced any side effects. Among those who 
experienced side effects, the response was as shown in 
table 5. 
 
Table 5: Experience of side effects 
Side effects  frequency Percent(%). 
Vomiting  
Nausea 
Alopecia 
Diarrhoea 
Fatigue 
Pain 
Loss of apatite 
Loss of libido 
Bleeding. 
Other side effects. 
160  
140  
141  
67  
157  
77  
42  
4  
1  
5 
83.8 
73.3 
73.8 
35.1 
82.2 
40.3 
23 
2.1 
0.5 
2.6 
 
The action taken by those who experienced side effects also varied. Some went back to see the doctor, some tolerated 
while others stopped the medication at least at one occasion as depicted in the table 6. 
Table 6: Action taken when experienced side effects 
Action  Frequency  Percentage 
Went back to doctor 
Tolerated 
Stopped medications. 
66 
70 
55 
34.6 
36.6 
28.8 
 
The participants were also interviewed if they had been 
informed and are aware of any medications which 
relieve the side effects. Only 8 respondents (3.7%) 
acknowledged to be aware while the majority, 208 
(96.3%) denied to have been informed. The study went 
on to assess the association between awareness and 
different variables; the result was as shown in the table 
7.
Informer  Frequency Percent 
 Doctor 68 77.3 
Nurse 19 21.6 
Friend 1 1.1 
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Table 7: The association between awareness and other variables 
Variable 
 
Awareness. 
Chi square value P value. 
Age 
Sex 
Occupation 
Level of education 
Residence 
Duration in chemotherapy 
Action 
Awareness of relief med. 
attitude 
2.90 
1.52 
9.18 
5.32 
2.13 
17.72 
7.72 
12.08 
10.86 
0.57 
0.21 
0.06 
0.15 
0.14 
0.01 
0.02 
0.01 
0.01 
 
There was a significant statistical association between 
participants being aware of the side effects and duration 
with which the patient has been on chemotherapy, action 
to take when side effects arise, awareness of side effects 
relieving medications and attitude towards the use of 
chemotherapy.  
Attitude towards chemotherapy use 
To determine the attitude towards the use of 
chemotherapy, the participants were asked to give the 
views towards the use. Most of respondents said 
chemotherapy was very helpful and they were ready to 
continue with chemotherapy. The results are shown in 
the table 8. 
Table 8: Attitude towards chemotherapy use 
Attitude. Frequency Percent 
 Positive. 197 91.2 
Negative. 19 8.8 
Total 216 100.0 
 
The associations between the attitude and different 
variables were determined and the results are shown in 
table 9. 
 
Table 9: The associations between attitude and other variables 
Variable. Attitude. 
Chi square  value P value 
Age 
Sex 
Marital status 
Occupation 
Level of education 
Religion 
Residence 
Duration in chemotherapy 
Awareness of SE. 
2.726 
0.219 
1.382 
2.689 
1.768 
7.714 
4.840 
3.976 
10.864 
0.61 
0.64 
0.71 
0.61 
0.62 
0.42 
0.52 
0.78 
0.01 
 
There was significant statistical association between 
participants being aware of the side effects and having 
positive attitude. 
DISCUSSION 
Awareness on the chemotherapy side effects 
With regard to awareness on chemotherapy side effects, 
participants were interviewed to find out if they had 
received any information regarding the side effects. It 
was found that only 88 respondents (40.7%) were aware 
of chemotherapy side effects before the start of 
chemotherapy. The lower rate of awareness among these 
participants would be attributed to lower number of 
health personnel working in this facility; therefore 
because of large burden of patients to health personnel, 
it would have made it difficult for patients to have 
enough time to receive all information. This rate was 
lower compared to study done by Julie Tompson, 2013 
in Canada whereby the awareness was 79% 
7,12
. This 
was indeed lower than the required rate of 100% by the 
WHO which require all patients to be aware of the side 
effects before the start of chemotherapy 
13
. Other similar 
studies done on the awareness of side effects of 
chemotherapy drugs used in treatment of various types 
of cancers showed slightly higher rate of awareness 
14,15,16
. 
 Although 88 (40.7%) of all participants were aware of 
chemotherapy side effects, majority of them were aware 
of vomiting (85, 96.6%), alopecia (82, 93.2%), nausea 
(62, 70.5%) and fatigue (62, 70.5%). This is probably 
because these are the side effects which occur 
immediately following the use of almost all 
chemotherapies and many patients are told about them 
by friends and primary care givers despite of expecting 
to be told by health care giver. Most of the respondents 
were not aware of anemia, bleeding, immune-
suppression and loss of appetite induced by 
chemotherapy. This is probably because these are late 
effects and some health care givers confuse them as 
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symptoms of disease itself. Similar trend of results were 
also reported by Lisa Ysela Ramirez et al in their study 
on Potential chemotherapy side effects, in their study 
they reported immediately occurring side effects as 
acute effect and others as late effects of chemotherapy 
17
.  
In a prospective cohort study on the incidence and 
severity of self-reported chemotherapy side effects in 
routine care, Alison Pearce et al revealed that 
chemotherapy side effects which are normally graded 
from grade 1 to 4 occurred in 86% of all participants of 
which 62% were moderate and severe side effects 
prompting them to seek medical care. This is slightly 
higher than that showed by our study of 88.4% 
signifying that the vast majority of patients on 
chemotherapy will suffer from significant side effects 
and this have been shown by many other studies 
18,20,21
.  
Having this knowledge, we expected participants who 
reported to have experienced side effect to take action. 
Among 191 respondents who experienced side effects, 
66 (34.6%) people went back to the doctor, 69 (36.9%) 
tolerated while 56 (29.3%) stopped the medication at 
least once. The difference of responses taken by 
participants was probably due to the fact that, the 
severity by which they experienced them was different, 
side effects were severe, moderately while to others they 
were mild. Usually management of chemotherapy side 
effect is a part of routine cancer management and 
patients are often told about management option 
available. Thus it was important to associate level of 
awareness and action taken by participants following the 
experience of side effect. There were a significant 
statistical association between the awareness of side 
effects and the action taken following the experience of 
side effects (p = 0.021). Furthermore some participants 
56 (29.3%) of who stopped medication at least at once 
were not aware of side effects predicting poor outcome 
from their treatment. This is one of many reasons some 
patients abandon conventional treatment as shown by an 
observational study by Moshe Frenkel in his article 
titled “Refusing treatment” published on May 2013 in 
the Oncologist Journal and other studies 
19, 20, 21, 22
. Prior 
information on the chemotherapy side effects helps to 
make the patients aware and also promote adherence. It 
was also found that there was a significant statistical 
association between awareness to side effects and the 
duration in treatment (p=0.013), those who were on 
treatment for long duration of time were aware 
compared to those who has been on treatment for short 
time. 
Attitude towards chemotherapy use 
Attitude is a settled way of thinking or feeling about 
something, it is a single strong indicator driving an 
individual into willingly accepting something. Attitude 
can be changed by pre or post choice information. We 
found that most of participants, 91.2% had positive 
attitude towards the use of chemotherapy. They said the 
use of chemotherapy was very helpful and their 
conditions have improved following the use of 
chemotherapy. Symptoms like swelling and excessive 
pain were reported to have decreased following the use 
of chemotherapy. These patients were so willing to 
continue receiving chemotherapy. The positive attitude 
showed by majority of participants was because of the 
benefit they gained after using them.  However some 
respondents showed negative attitude and said that they 
did not find it beneficial to be on chemotherapy. This 
probably because, they received chemotherapy while 
their disease has been metastasized or they had wrong 
regimen of chemotherapy for a particular type of cancer. 
This rate of attitude is high similarly to multisite survey 
study on willingness to accept chemotherapy and 
attitude towards cost of cancer treatments done in 
Netherlands in which almost all patients accepted 
chemotherapy. Many studies show the attitude of 
patients towards chemotherapy to be positive 
23, 24, 25, 26
. 
There was a significant statistical association between 
awareness of side effects and attitude towards the 
chemotherapy use (p=0.01). Those who were aware of 
the side effects had positive attitude while others the 
positive attitude were attributed by the benefit gained or 
expected following the use of chemotherapy. 
CONCLUSION 
The study found there was poor level of awareness of 
the chemotherapy side effects and higher level of 
positive attitude towards chemotherapy use among 
patients attending and receiving chemotherapy in 
oncology unit at Bugando Medical Centre. Only small 
portion of the respondents was aware of the 
chemotherapy side effects.  
It was also found that those who were informed were 
aware only of few side effects. Moreover, the study 
revealed that unawareness of side effects affected 
adherence as most of the respondents who stopped 
medication were not aware of the side effects. It was 
also found that the pharmacists did not play their role to 
counsel and inform patients on the chemotherapy side 
effects. 
RECOMMENDATIONS 
The patients need to get informed thoroughly on the side 
effects of chemotherapy before they start treatment. 
Recorded videos giving relevant information are to be 
played in the rest room, but also the prepared brochures 
should be provided. We also recommend that other 
study to be done to assess the factors which might be 
impeding the transfer of information on side effects of 
chemotherapy to the patients. 
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